|
Originally published In Press as doi:10.1074/jbc.M204406200 on May 31, 2002
J. Biol. Chem., Vol. 277, Issue 32, 29242-29252, August 9, 2002
Contribution of Molecular Modeling and Site-directed Mutagenesis
to the Identification of Two Structural Residues, Arg-220 and
Asp-227, in Aminopeptidase A*
Raphaël
Rozenfeld ,
Xavier
Iturrioz ,
Bernard
Maigret§, and
Catherine
Llorens-Cortes ¶
From INSERM, Unité 36, Collège de France,
11, place Marcelin Berthelot, 75005 Paris and § CNRS,
Unité Mixte de Recherche 7565, Laboratoire de Chimie
Théorique, Université de Nancy,
54506 Vandoeuvre-les-Nancy, France
Aminopeptidase A is a zinc metalloenzyme involved
in the formation of brain angiotensin III, which exerts a tonic
stimulatory action on the central control of blood pressure. Thus,
central inhibitors of aminopeptidase A constitute putative central
antihypertensive agents. Mutagenic studies have been performed to
investigate organization of the aminopeptidase A active site, with a
view to designing such inhibitors. The structure of one monozinc
aminopeptidase (leukotriene A4 hydrolase) was
recently resolved and used to construct a three-dimensional model of
the aminopeptidase A ectodomain. This new model, highly consistent with
the results of mutagenic studies, showed a critical structural
interaction between two conserved residues, Arg-220 and Asp-227.
Mutagenic replacement of either of these two residues disrupted
maturation and subcellular localization and abolished the enzymatic
activity of aminopeptidase A, confirming the critical structural role
of these residues. In this study, we generated the first
three-dimensional model of a strict aminopeptidase, aminopeptidase
A. This model constitutes a new tool to probe further the active site
of aminopeptidase A and to design new inhibitors of this enzyme.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
33-1-44-27-1663; Fax: 33-1-44-27-1691; E-mail:
c.llorens-cortes@college-de-france.fr.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Claperon, I. Banegas-Font, X. Iturrioz, R. Rozenfeld, B. Maigret, and C. Llorens-Cortes
Identification of Threonine 348 as a Residue Involved in Aminopeptidase A Substrate Specificity
J. Biol. Chem.,
April 17, 2009;
284(16):
10618 - 10626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bodineau, A. Frugiere, Y. Marc, N. Inguimbert, C. Fassot, F. Balavoine, B. Roques, and C. Llorens-Cortes
Orally Active Aminopeptidase A Inhibitors Reduce Blood Pressure: A New Strategy for Treating Hypertension
Hypertension,
May 1, 2008;
51(5):
1318 - 1325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Goto, A. Hattori, Y. Ishii, S. Mizutani, and M. Tsujimoto
Enzymatic Properties of Human Aminopeptidase A: REGULATION OF ITS ENZYMATIC ACTIVITY BY CALCIUM AND ANGIOTENSIN IV
J. Biol. Chem.,
August 18, 2006;
281(33):
23503 - 23513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chavez-Gutierrez, E. Matta-Camacho, J. Osuna, E. Horjales, P. Joseph-Bravo, B. Maigret, and J.-L. Charli
Homology Modeling and Site-directed Mutagenesis of Pyroglutamyl Peptidase II: INSIGHTS INTO OMEGA-VERSUS AMINOPEPTIDASE SPECIFICITY IN THE M1 FAMILY
J. Biol. Chem.,
July 7, 2006;
281(27):
18581 - 18590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rozenfeld, L. Muller, S. E. Messari, and C. Llorens-Cortes
The C-terminal Domain of Aminopeptidase A Is an Intramolecular Chaperone Required for the Correct Folding, Cell Surface Expression, and Activity of This Monozinc Aminopeptidase
J. Biol. Chem.,
October 8, 2004;
279(41):
43285 - 43295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-C. Fournie-Zaluski, C. Fassot, B. Valentin, D. Djordjijevic, A. Reaux-Le Goazigo, P. Corvol, B. P. Roques, and C. Llorens-Cortes
Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: A potential treatment of salt-dependent hypertension
PNAS,
May 18, 2004;
101(20):
7775 - 7780.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|